Cargando…

Adipocytes ESR1 Expression, Body Fat and Response to Testosterone Therapy in Hypogonadal Men Vary According to Estradiol Levels

Estradiol (E2), mainly produced from Testosterone (T) in men, promotes visceral lipolysis. However, high visceral fat and hyperestrogenemia are features of obese hypogonadal (HG) men. Our study objectives are to evaluate relationships between circulating E2 and: (1) fat mass; (2) Estrogen Receptor α...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colleluori, Georgia, Aguirre, Lina E., Qualls, Clifford, Chen, Rui, Napoli, Nicola, Villareal, Dennis T., Armamento-Villareal, Reina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164305/ https://www.ncbi.nlm.nih.gov/pubmed/30181488 http://dx.doi.org/10.3390/nu10091226

Ejemplares similares

Fat Mass Follows a U-Shaped Distribution Based on Estradiol Levels in Postmenopausal Women
por: Colleluori, Georgia, et al.
Publicado: (2018)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022)

OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023)

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
por: Colleluori, Georgia, et al.
Publicado: (2020)

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults
por: Colleluori, Georgia, et al.
Publicado: (2017)

Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial
por: Bouchonville, Matthew, et al.
Publicado: (2013)

Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults
por: Aguirre, Lina E., et al.
Publicado: (2014)

Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
por: Russo, Vittoria, et al.
Publicado: (2021)

Fat, Muscle, and Bone Interactions in Obesity and the Metabolic Syndrome
por: Armamento-Villareal, Reina, et al.
Publicado: (2014)

Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa, et al.
Publicado: (2021)

MON-382 Bone Quality and Strength in Obese Men with Type 2 Diabetes Mellitus Are Impaired and Negatively Influenced by Adiposity
por: Vigevano, Francesca, et al.
Publicado: (2020)

Hemoglobin A1c of 7% is the Threshold For Bone Impairment in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa Salim, et al.
Publicado: (2021)

SUN-541 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Frail, Older Male Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Barnouin, Yoann, et al.
Publicado: (2020)

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity
por: Gregori, Giulia, et al.
Publicado: (2023)

The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds
por: Armamento-Villareal, Reina, et al.
Publicado: (2016)

OR02-05 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention on Cognitive Functions in Frail, Older Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Gregori, Giulia, et al.
Publicado: (2020)

Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus
por: Ballato, Elliot, et al.
Publicado: (2022)

ODP101 In Men with Type 2 Diabetes Mellitus, Poor Glycemic Control is Associated with Diminished Circulating Osteoblast Progenitors
por: Ballato, Elliot, et al.
Publicado: (2022)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review
por: Deepika, Fnu, et al.
Publicado: (2023)

Sarcopenic Obesity Indices Are Major Determinants of Bone Strength in Older Adults With Obesity
por: Gregori, Giulia, et al.
Publicado: (2021)

Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism
por: Çelik, Mehmet, et al.
Publicado: (2021)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

110. Bone Mineral Density Screening in Veterans Living with HIV
por: Khanjee, Naveed, et al.
Publicado: (2020)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS
por: Nesheim, Nils, et al.
Publicado: (2018)

Testosterone-Associated Dietary Pattern Predicts Low Testosterone Levels and Hypogonadism
por: Hu, Tzu-Yu, et al.
Publicado: (2018)

A Review of Testosterone Pellets in the Treatment of Hypogonadism
por: McCullough, Andrew
Publicado: (2014)

Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015)

Mammary gland adipocytes in lactation cycle, obesity and breast cancer
por: Colleluori, Georgia, et al.
Publicado: (2021)

Heightened levels of plasma growth differentiation factor 15 in men living with HIV
por: Agarwal, Neeti, et al.
Publicado: (2022)

Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study
por: Defeudis, Giuseppe, et al.
Publicado: (2022)

Inhibitory effect of 17β-estradiol on triglyceride synthesis in skeletal muscle cells is dependent on ESR1 and not ESR2
por: Liu, Quan, et al.
Publicado: (2019)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009)

Effects of estradiol and FSH on maturation of the testis in the hypogonadal (hpg) mouse
por: Baines, Helen, et al.
Publicado: (2008)

Challenges and improvements in testosterone and estradiol testing
por: Vesper, Hubert W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6rnbpqvk35ep8rbsvqna4p20f7